Home - Biotech Newswire
Search
HOME
ABOUT US
ABOUT US
SPECIALIZED CHANNELS
ARTIFICIAL INTELLIGENCE
DISTRIBUTION OPTIONS
REFERENCES
PARTNERS
NEWSROOM
EDITOR SIGN-UP
CONTACT
Request a Demo
The
life science
and biotech PR distribution service
All Biotech News
List of articles in category All Biotech News
Title
Published Date
BD, Accelerate Diagnostics Announce Global Commercial Collaboration
08/15/2022
CYTENA Unveils New Generation of B.SIGHT, a Fully Automated Single-Cell Dispenser for Microorganisms
08/08/2022
U.S. Food and Drug Administration (FDA) Approves FYB201/CIMERLI™* (ranibizumab-eqrn), the First and Only Biosimilar Interchangeable with Lucentis®**
08/03/2022
BioMed X Institute and Healthcare Business of Merck KGaA, Darmstadt, Germany, Start New Research Project in Oncology
08/01/2022
SOTIO Doses First Patient in AURELIO-04 Phase 2 Trial of SOT101 in Combination with KEYTRUDA® (pembrolizumab)
07/26/2022
Developing a Variant-Proof SARS-CoV-2 Vaccine: a CEPI-funded ExcellGene Partnership with Bharat Biotech and the University of Sydney
07/26/2022
Polpharma Biologics Announces FDA File Acceptance for Review of Natalizumab, First Proposed Biosimilar to Tysabri®
07/25/2022
NEOsphere Biotechnologies Closes Financing Round to Discover Therapeutic Protein Degraders Via Expanded Proteomics Platform
07/25/2022
Navigo Proteins Successfully Develops Affinity Resin Against Ferritin for Blood Fraction Processing
07/20/2022
Apaxen Appoints Graham K. Dixon as Chairman and Prepares for Clinical Testing of its Lead Inflammasome Inhibitor
07/18/2022
Polpharma Biologics Announces EMA Acceptance of Marketing Authorization Application for Proposed Biosimilar Natalizumab
07/15/2022
ProBioGen Teams Up with Granite Bio for Cell Line Development and GMP Manufacturing Services
07/12/2022
Accelerate Diagnostics Announces Commercialization in Europe of its Accelerate Arc™ System Having Completed IVDR Registration
07/11/2022
ProteoNic Announces Licensing of its Premium 2G UNic™ Technology Platform for Production of Biologics to FyoniBio
07/05/2022
Vetter’s Newest Clinical Manufacturing Site Successfully Completed its First Customer Fills
06/28/2022
Richard Wales, Ph.D., and Neil Bargh of Sartorius Honored as Recipients of 2022 ESACT Innovation Award for the Development of the Sartorius Ambr® Technology
06/28/2022
ICPO Foundation Presents its first Maurits W. Geerlings Actinium-225 Next Generation Award to Dr. Madhav Yadav from AIIMS, India at the 6th Theranostics World Congress (TWC)
06/28/2022
Ixaka and Minaris Regenerative Medicine Sign Tech Transfer and GMP Manufacturing Agreement for Lead Cell Therapy Candidate REX-001
06/27/2022
ProtonDx New Rapid Multi-Viral Pathogen Detection System Receives CE-IVD Mark
06/21/2022
ProteoNic Announces Licensing of its 2G UNic™ Technology Platform for Production of Biologics to GenScript ProBio
06/15/2022
ValenzaBio Engages ProBioGen For a Second Service Project
06/14/2022
PEPperPRINT GmbH Introduces Novel Biomarker Set for Rheumatoid Arthritis Diagnosis at the 13th International Congress on Autoimmunity
06/09/2022
Cellbox Solutions Releases Its New Product Generation - Cellbox 2.0 - Innovative Portable Incubator Now with Longer Runtime, CFR21/11 Clinical Trial Compatibility and More
06/08/2022
CYTENA Enters Long Term OEM Supply Agreement with PAIA and Launches the F.QUANT Titer, High-Throughput Titer Quantification Assays for Antibodies and Fc Fusion Proteins
06/07/2022
Coriolis Pharma Invests in Growth by Creating a New Campus in Martinsried-Munich
06/03/2022
ProBioGen Grows by 50 Percent in Last Two Years
06/02/2022
4P-Pharma and Delta 4 Join Forces to Find and Develop Treatments for a Rare Autoimmune Chronic Liver Disease
06/02/2022
Navigo Proteins Announces Launch of an Exclusive Affinity Resin for the Capture of gp64
06/02/2022
Vetter Publishes First Sustainability Report
06/01/2022
Samanta Cimitan Appointed Chief Business Officer at Celonic
06/01/2022
Page 6 of 79
Start
Prev
1
2
3
4
5
6
7
8
9
10
Next
End
Cookies make it easier for us to provide you with our services. With the usage of our services you permit us to use cookies.
Ok